Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02131597
Title SGI-110 in Higher Risk Myelodysplastic Syndrome (MDS)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

bone marrow cancer

Therapies

Guadecitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.